Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,882,654
Closed -$3.75M 157
2025
Q2
$3.75M Hold
1,882,654
0.07% 77
2025
Q1
$2.73M Hold
1,882,654
0.05% 81
2024
Q4
$3.9M Hold
1,882,654
0.07% 73
2024
Q3
$3.31M Sell
1,882,654
-2,121,577
-53% -$5.44M 0.05% 75
2024
Q2
$57.9M Hold
4,004,231
0.96% 25
2024
Q1
$66.6M Hold
4,004,231
1.16% 23
2023
Q4
$64.3M Hold
4,004,231
1.19% 24
2023
Q3
$53.9M Buy
4,004,231
+675,000
+20% +$9.5M 1.19% 22
2023
Q2
$57.2M Buy
3,329,231
+495,541
+17% +$7.68M 1.22% 21
2023
Q1
$46.8M Buy
2,833,690
+139,589
+5% +$2.23M 1.04% 30
2022
Q4
$45.1M Buy
2,694,101
+40,870
+2% +$738K 0.93% 31
2022
Q3
$45.3M Buy
2,653,231
+35,283
+1% +$513K 0.9% 36
2022
Q2
$28.6M Buy
+2,617,948
New +$31.1M 0.59% 49

Deerfield Management's HLVX Position: Q3 2025 in Review

Deerfield Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 1,882,654 shares — an estimated $3.75M sold.

Deerfield Management first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $66.6M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Deerfield Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Deerfield Management sold 1,882,654 HilleVax shares in Q3 2025, an estimated $3.75M.
  • Deerfield Management first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
  • Deerfield Management's HilleVax position peaked at $66.6M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.